Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Mouse P2Y 4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation.

Lemaire A., Vanorlé M., Horckmans M., di Pietrantonio L., Clouet S., Robaye B.

Animal Study on Cardiovascular Disease, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Stem Cells Dev (2016)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
27855539
DOI
10.1089/scd.2016.0166
Citations
22

Abstract (original English)

Cardiac adipose tissue-derived stem cells (cASCs) have the ability to differentiate into multiple cell lineages giving them a high potential for use in regenerative medicine. Cardiac fat tissue still raises many unsolved questions related to its formation and features. P2Y nucleotide receptors have already been described as regulators of differentiation of bone-marrow derived stem cells, but remain poorly investigated in cASCs. We defined, in this study, the P2Y 4 nucleotide receptor as a negative regulator of cardiac fat formation and cASC adipogenic differentiation. Higher expression of P2Y 4 receptor in cardiac fat tissue was observed compared to other adipose tissues. P2Y 4 -null mice displayed a higher mass of cardiac adipose tissue specifically. We therefore examined the role of P2Y 4 receptor in cASC adipogenic differentiation. An inhibitory effect of uridine 5'-triphosphate (UTP), ligand of P2Y 4 , was observed on the maturation state of differentiated cASCs, and on the expression of adipogenesis-linked genes and adiponectin, a cardioprotective adipokine. Higher adiponectin secretion by P2Y 4 -null adipocytes could be linked with cardioprotection previously observed in the heart of P2Y 4 -null ischemic mice. We realized here left anterior descending artery ligation on simple and double-knockout mice for P2Y 4 and adiponectin. No cardioprotective effect of P2Y 4 loss was

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipogenesisAdiponectinAdipose TissueAdiposityAnimalsBiomarkersCardiotonic AgentsCell DifferentiationCell Hypoxia

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research